APA

Reich K., Pinter A., Lacour J. P., Ferrandiz C., Micali G., French L. E., Lomaga M., Dutronc Y., Henneges C., Wilhelm S., Hartz S. & Paul C. (20180618). Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study. : The British journal of dermatology.

Chicago

Reich K, Pinter A, Lacour J P, Ferrandiz C, Micali G, French L E, Lomaga M, Dutronc Y, Henneges C, Wilhelm S, Hartz S and Paul C. 20180618. Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study. : The British journal of dermatology.

Harvard

Reich K., Pinter A., Lacour J. P., Ferrandiz C., Micali G., French L. E., Lomaga M., Dutronc Y., Henneges C., Wilhelm S., Hartz S. and Paul C. (20180618). Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study. : The British journal of dermatology.

MLA

Reich K, Pinter A, Lacour J P, Ferrandiz C, Micali G, French L E, Lomaga M, Dutronc Y, Henneges C, Wilhelm S, Hartz S and Paul C. Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study. : The British journal of dermatology. 20180618.